Potential drug repurposing of ruxolitinib to inhibit the JAK/STAT pathway for the treatment of patients with epithelial ovarian cancer
Article in Journal of Obstetrics and Gynaecology Research (August 2023)
The most recent citing publications are shown below. View all 65 publications that cite this research output on Dimensions.
Article in Journal of Obstetrics and Gynaecology Research (August 2023)
Article in Frontiers in Oncology (July 2023)
Article in Biophysica (July 2023)